Abstract:In calcium nephrolithiasis (CaNL), most calcium kidney stones are identified as calcium oxalate (CaOx) with variable amounts of calcium phosphate (CaP), where CaP is found as the core component. The nucleation of CaP could be the first step of CaP+CaOx (mixed) stone formation. High urinary supersaturation of CaP due to hypercalciuria and an elevated urine pH have been described as the two main factors in the nucleation of CaP crystals. Our previous in vivo findings (in mice) show that transient receptor potential canonical type 3 (TRPC3)-mediated Ca2+ entry triggers a transepithelial Ca2+ flux to regulate proximal tubular (PT) luminal [Ca2+], and TRPC3-knockout (KO; -/-) mice exhibited moderate hypercalciuria and microcrystal formation at the loop of Henle (LOH). Therefore, we utilized TRPC3 KO mice and exposed them to both hypercalciuric [2% calcium gluconate (CaG) treatment] and alkalineuric conditions [0.08% acetazolamide (ACZ) treatment] to generate a CaNL phenotype. Our results revealed a significant CaP and mixed crystal formation in those treated KO mice (KOT) compared to their WT counterparts (WTT). Importantly, prolonged exposure to CaG and ACZ resulted in a further increase in crystal size for both treated groups (WTT and KOT), but the KOT mice crystal sizes were markedly larger. Moreover, kidney tissue sections of the KOT mice displayed a greater CaP and mixed microcrystal formation than the kidney sections of the WTT group, specifically in the outer and inner medullary and calyceal region; thus, a higher degree of calcifications and mixed calcium lithiasis in the kidneys of the KOT group was displayed. In our effort to find the Ca2+ signaling pathophysiology of PT cells, we found that PT cells from both treated groups (WTT and KOT) elicited a larger Ca2+ entry compared to the WT counterparts because of significant inhibition by the store-operated Ca2+ entry (SOCE) inhibitor, Pyr6. In the presence of both SOCE (Pyr6) and ROCE (receptor-operated Ca2+ entry) inhibitors (Pyr10), Ca2+ entry by WTT cells was moderately inhibited, suggesting that the Ca2+ and pH levels exerted sensitivity changes in response to ROCE and SOCE. An assessment of the gene expression profiles in the PT cells of WTT and KOT mice revealed a safeguarding effect of TRPC3 against detrimental processes (calcification, fibrosis, inflammation, and apoptosis) in the presence of higher pH and hypercalciuric conditions in mice. Together, these findings show that compromise in both the ROCE and SOCE mechanisms in the absence of TRPC3 under hypercalciuric plus higher tubular pH conditions results in higher CaP and mixed crystal formation and that TRPC3 is protective against those adverse effects.

Abnormal expression of Ca2+active transport proteins on basolateral membrane of renal tubule epithelial cells in kidney of rats with genetic hypercalciuric stone-forming and implication

The Expression and Implication of TRPV5, Calbindin-D28k and NCX1 in Idiopathic Hypercalciuria

[Expression of Calbindin-D28k in Genetic Hypercalciuric Stone-Forming Rats Kidney and Its Role in Pathogenesis of Idiopathic Hypercalciuria].

Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats

Expression of calcium ion channel TRPV5 in kidneys of genetic hypercalciuric stone-forming rats

Does Crystal Deposition in Genetic Hypercalciuric Rat Kidney Tissue Share Similarities With Bone Formation?

Expression of Osteopontin and CD44 in Kidneys of GHS Rats and Their Correlation with Kidney Interstitial Calcification

The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation

Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis

Vacuolar H+-ATPase expression is increased in acid-secreting intercalated cells in kidneys of rats with hypercalcaemia-induced alkalosis

Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats

Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat

Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion

Adenovirus-delivered microRNA targeting the vitamin D receptor reduces intracellular Ca2+ concentrations by regulating the expression of Ca2+-transport proteins in renal epithelial cells: VDR-DEPENDENT REGULATION OF Ca2+-TRANSPORT PROTEINS

Analysis Of Altered Microrna Expression Profiles In Proximal Renal Tubular Cells In Response To Calcium Oxalate Monohydrate Crystal Adhesion: Implications For Kidney Stone Disease

Renal handling of calcium in hypercalciuric calcium oxalate nephrolithiasis

Hypertension and renal calcium transport

Inhibitory role of microRNA-484 in kidney stone formation by repressing calcium oxalate crystallization via a VDR/FoxO1 regulator axis

miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis

Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet

Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients